AIM
INFI

Ada Investment Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Ada Investment Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$186K Buy
+23,663
New +$204K 0.13% 342

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ada Investment Management's INFI Position: Q4 2015 in Review

Ada Investment Management opened a new position in Infinity Pharmaceuticals, Inc. (INFI) in Q4 2015: 23,663 shares worth $186K. The stake represents 0.13% of the portfolio and ranks #342 among its holdings.

115 funds tracked by Wall St. Rank hold INFI as of Q4 2015.

  • Ada Investment Management held 23,663 shares of Infinity Pharmaceuticals, Inc. worth $186K as of Q4 2015.
  • Infinity Pharmaceuticals, Inc. was a new Ada Investment Management position in Q4 2015.
  • Infinity Pharmaceuticals, Inc. made up 0.13% of Ada Investment Management's portfolio in Q4 2015, its #342 holding.
  • 115 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.